Developing Covid-19 vaccines at pandemic speed
N Lurie, M Saville, R Hatchett… - New England journal of …, 2020 - Mass Medical Soc
Developing Covid-19 Vaccines at Pandemic Speed An ideal vaccine platform would support
development from viral sequencing to clinical trials in less than 16 weeks, demonstrate …
development from viral sequencing to clinical trials in less than 16 weeks, demonstrate …
Boosting immunity to COVID-19 vaccines
JA Juno, AK Wheatley - Nature medicine, 2021 - nature.com
Boosting immunity to COVID-19 vaccines | Nature Medicine Skip to main content Thank you for
visiting nature.com. You are using a browser version with limited support for CSS. To obtain the …
visiting nature.com. You are using a browser version with limited support for CSS. To obtain the …
A COVID-19 vaccine: big strides come with big challenges
J Mellet, MS Pepper - Vaccines, 2021 - mdpi.com
As of 8 January 2021, there were 86,749,940 confirmed coronavirus disease 2019 (COVID-
19) cases and 1,890,342 COVID-19-related deaths worldwide, as reported by the World …
19) cases and 1,890,342 COVID-19-related deaths worldwide, as reported by the World …
[HTML][HTML] Emergency use authorization of Covid vaccines—safety and efficacy follow-up considerations
PR Krause, MF Gruber - New England Journal of Medicine, 2020 - Mass Medical Soc
Emergency Use Authorization of Covid Vaccines A median 2-month follow-up after
completion of an investigational Covid-19 vaccine regimen is necessary to provide safety …
completion of an investigational Covid-19 vaccine regimen is necessary to provide safety …
[HTML][HTML] SARS-CoV-2 vaccines in advanced clinical trials: Where do we stand?
The ongoing SARS-CoV-2 pandemic has led to the focused application of resources and
scientific expertise toward the goal of developing investigational vaccines to prevent COVID …
scientific expertise toward the goal of developing investigational vaccines to prevent COVID …
[HTML][HTML] Current status of COVID-19 vaccine development: focusing on antigen design and clinical trials on later stages
P Lee, CU Kim, SH Seo, DJ Kim - Immune network, 2021 - ncbi.nlm.nih.gov
The global outbreak of coronavirus disease 2019 (COVID-19) is still threatening human
health, economy, and social life worldwide. As a counteraction for this devastating disease …
health, economy, and social life worldwide. As a counteraction for this devastating disease …
Efficacy, immunogenicity and safety of COVID-19 vaccines: a systematic review and meta-analysis
There is a significant research gap in meta-analysis on the efficacy and safety of coronavirus
disease 2019 (COVID-19) vaccines. This study analyzed the efficacy of COVID-19 vaccines …
disease 2019 (COVID-19) vaccines. This study analyzed the efficacy of COVID-19 vaccines …
Unwavering regulatory safeguards for COVID-19 vaccines
A Shah, PW Marks, SM Hahn - Jama, 2020 - jamanetwork.com
The coronavirus disease 2019 (COVID-19) pandemic has disrupted normal life and had
significant consequences for human health, with more than 4.6 million cases and more than …
significant consequences for human health, with more than 4.6 million cases and more than …
Clinical development and approval of COVID-19 vaccines
U Kalinke, DH Barouch, R Rizzi… - Expert Review of …, 2022 - Taylor & Francis
ABSTRACT Introduction The coronavirus 19 (COVID-19) pandemic triggered a
simultaneous global demand for preventative vaccines, which quickly became a high priority …
simultaneous global demand for preventative vaccines, which quickly became a high priority …
Vaccines for COVID-19: a systematic review of feasibility and effectiveness
Introduction: Many potential vaccines for COVID-19 are being studied and developed.
Several studies have reported on the safety and efficacy of these vaccines. This systematic …
Several studies have reported on the safety and efficacy of these vaccines. This systematic …